Proficio Capital Partners LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 33,476 shares of the pharmacy operator’s stock, valued at approximately $312,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. First Financial Corp IN grew its holdings in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at about $26,000. Riverview Trust Co grew its holdings in shares of Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,590 shares during the period. Venturi Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth about $28,000. Finally, TD Private Client Wealth LLC raised its stake in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on WBA. Evercore ISI raised their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their target price for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Bank of America upped their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and an average target price of $10.59.
Walgreens Boots Alliance Price Performance
Walgreens Boots Alliance stock opened at $11.12 on Wednesday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The firm has a market cap of $9.61 billion, a PE ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The company’s 50 day moving average is $10.92 and its two-hundred day moving average is $9.87.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same period last year, the business posted $0.66 earnings per share. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
- Five stocks we like better than Walgreens Boots Alliance
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How is Compound Interest Calculated?
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Compound Interest and Why It Matters When Investing
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.